Loading quotes...
Forecast
The analysts' average price target is €22.76 (+46.18%). The median is €22.87 (+46.89%).
| Buy |
15 |
| Hold |
22 |
| Sell |
2 |
News Go to news feed
Icade boosts liquidity through sale of Marignan despite revenue decline in Q1 2026
Icade sold the Marignan asset for €402m, raising liquidity to around €2.8bn and cutting the loan-to-value ratio by about 3 percentage points. Operationally, consolidated revenues in the first quarter fell 14.7% to €278.2m; gross rents and project development collapsed. The occupancy rate dropped to 85.0%, while project development order volume rose 4% but the value of orders fell 21%. Icade confirms its 2026 guidance and stresses that the portfolio measures create financial flexibility amid pressure in the leasing market. » More on de.investing.com
ICADE confirms annual target after €430m disposals and 9% revenue decline
ICADE recorded a consolidated revenue decline of 9% to €923.0m in the first nine months of 2025. The company completed strategic disposals totaling around €430m, of which €210m were in the healthcare sector and €220m from mature or non-strategic assets. Despite lower revenues, ICADE highlighted solid leasing metrics and confirmed its full-year guidance with NCCF per share of €3.40–3.60. Management expects a slow recovery in project development no earlier than 2027 and continues to focus on portfolio optimization and selective disposals. » More on de.investing.com
ICADE increases EBITDA despite revenue decline and focuses on diversification
In the first quarter of 2025, ICADE reported a 10% drop in revenue to €630 million, but managed to significantly increase EBITDA to €145 million. The company highlights its strategic shift towards diversification and resilience in response to a challenging real estate market, particularly through investments in student housing and light industrial assets. CEO Nicolas Jolie emphasizes a pragmatic approach to pricing and expects a market recovery by 2027. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | July 2026 | YoY |
|---|---|---|
| Revenue | 442.55m | 9.37% |
| Gross profit | 205.63m | 8.01% |
| Net profit | 27.27m | 19.23% |
| EBITDA | 46.49m | 12.34% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.57bn |
Number of shares | 82.07m |
52-week high/low | €21.38 - €12.56 |
Dividend yield | 12.31% |
Dividends TTM | €1.92 |
Beta | 1.68 |
P/E ratio | 16.41 |
PEG ratio | 0.63 |
P/B ratio | 4.00 |
P/S ratio | 0.90 |
Company profile
As an investor and a developer, Icade is an integrated real estate player that designs innovative real estate products and services adapted to new urban lifestyles and habits. By placing corporate social responsibility and innovation at the core of its strategy, Icade is closely involved with stakeholders and users in the cities—local authorities and communities, companies and employees, institutions and associations. As an office and healthcare property investor (portfolio value of €11.6bn as of 06/30/2020 on a proportionate consolidation basis) and as a property developer (2019 economic revenues of nearly €1bn), Icade has been able to reinvent the real estate business and foster the emergence of tomorrow's greener, smarter and more responsible cities. Icade is a significant player in the Greater Paris area and major French cities. Icade is listed on Euronext Paris as a French Listed Real Estate Investment Company (société d'investissement immobilier cotée, SIIC). Its leading shareholder is the Caisse des dépôts Group.
| Name | Icade |
| CEO | Christopher E. Hufnagel |
| Headquarters | Rockford,
mi France |
| Website | |
| Sector | Real Estate |
| Industry | Real Estate Management & Development |
| IPO | 01/12/2006 |
| Employees | 3,050 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Euronext | ICAD.PA |
Düsseldorf | 3IC.DU |
Frankfurt | 3IC.F |
London | 0K4O.L |
München | 3IC.MU |
Paris | ICAD.PA |
Pnk | CDMGF |
AMEX | PGF |
Toronto Stock Exchange | STPL.TO |
NYSE | WWW |
SIX | ICAD.SW |